NCI Cancer Hospital

What NCI Cancer Hospital does

NCI Community Oncology Research Program (NCORP) is a federally funded national network operated by the National Cancer Institute (NCI), within the National Institutes of Health under the U.S. Department of Health and Human Services. NCORP brings cancer clinical trials and cancer care delivery studies to patients in their own communities through more than 1,000 medical practices at diverse, community-based hospitals and practices, organized under 33+ main grantee sites that include Research Bases, Community Sites, and Academic Community Sites. The program succeeded the earlier Community Clinical Oncology Program (CCOP) and today covers the United States, Puerto Rico, and Guam, with designated minority/underserved site tracks aimed at reducing disparities in trial access. NCORP's research portfolio spans cancer prevention, screening, treatment, symptom management, and care delivery, with notable outputs including the TMIST breast cancer screening trial (enrollment goal achieved in January 2025 through the ECOG-ACRN research-base partnership) and an ASCO 2024 finding that olanzapine may reduce chemotherapy-induced nausea.

The program's core platform is its distributed network infrastructure: a national backbone of grantee sites with hundreds of affiliate and sub-affiliate hospitals, supported by educational webinars and videos on clinical trial design, patient safety, precision medicine, patient-reported outcomes integration, and symptom management quality-of-life concept design. NCORP does not sell products or services; it is funded through federal appropriations and administered through Notices of Funding Opportunities (NOFOs) that award grants to Research Bases, Community Sites, and Academic Community Sites, with per-case reimbursement rates set for clinical trial activities. There is no commercial pricing model.

NCORP serves three constituencies: cancer patients in community settings who gain access to NCI-sponsored trials without traveling to academic medical centers; academic investigators seeking community-based research infrastructure and patient access; and community hospitals and physician practices that want to offer NCI-sponsored trials locally. Strategic partners include integrated delivery systems such as Kaiser Permanente NCORP (68+ affiliate locations across California, Colorado, Georgia, Hawaii, Oregon, and Washington), multi-state consortia such as the Southeast Clinical Oncology Research Consortium (70+ affiliates) and Aurora NCORP (Illinois and Wisconsin, 40+ affiliates), and research-base partner ECOG-ACRN. Following Worta McCaskill-Stevens' retirement on October 31, 2023, Brandy Heckman-Stoddard serves as Acting Director while a nationwide search for a permanent replacement is underway.

Name

NCI Cancer Hospital

Legal name

NCI Community Oncology Research Program (NCORP)

Website

https://ncorp.cancer.gov

Company type

Private

Founded year

1937

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

NCORP is a federally funded NCI network that delivers cancer clinical trials and care delivery studies to patients through more than 1,000 community-based hospitals and practices across the United States, Puerto Rico, and Guam.

Ownership category

akta.pro rank

Product category

Clinical Trials Research Network

SIC

Services-Health Services (8000)

akta.pro primary industry

Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer) (HLAJANAG)

akta.pro secondary industry

Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Clinical trials network
• Cancer prevention research
• Oncology care delivery
• Community oncology studies
• Cancer research infrastructure

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Government Research Grants: NCORP is a federally funded research program operated by the National Cancer Institute (NCI), part of the National Institutes of Health. The program provides funding opportunities through Notice of Funding Opportunities (NOFOs) for Research Bases, Community Sites, and Academic Community Sites. Reimbursement rates for clinical trial activities are provided per-case based on study type categories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

NCORP is a national network that brings cancer clinical trials and cancer care delivery studies to people in their own communities through more than 1,000 diverse, community-based hospitals and practices. The program facilitates research on cancer prevention, symptoms from cancer and its treatment, cancer screening, and cancer care delivery in local community settings. It connects patients to research opportunities through a network of over 1,000 community-based hospitals and practices across the United States.

Product overview

NCORP is a single unified national research network program operated by the National Cancer Institute. The program facilitates cancer clinical trials and cancer care delivery studies focused on cancer prevention, symptoms from cancer and its treatment, cancer screening, and cancer care delivery in local community settings. It connects patients to research opportunities through a network of over 1,000 community-based hospitals and practices across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• NCI Community Oncology Research Program (NCORP) A national network program operated by the National Cancer Institute that brings cancer clinical trials and cancer care delivery studies to people in their communities through more than 1,000 medical practices at diverse, community-based hospitals and practices. It facilitates research on cancer prevention, symptoms from cancer and its treatment, cancer screening, and cancer care delivery in local community settings.

Quantifiable outcome

• NCORP-supported research demonstrated that Olanzapine may reduce chemotherapy-induced nausea (ASCO 2024)
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered strategic and core.

• ECOG-ACRNstrategicStrategic or Co-development Partner · 24 August 2023Research Base partner; Large-scale TMIST breast cancer screening trial achieved enrollment goal through ECOG-ACRN partnership, enabling precision approach to breast cancer screening.
• Atlantic Health Cancer ConsortiumcoreStrategic or Co-development PartnerNCORP community site grantee serving New Jersey with principal investigator Eric D. Whitman, MD. Network includes affiliate hospitals such as Morristown Medical Center, Overlook Medical Center, and Saint Peter's University Hospital across New Jersey communities.
• Aurora NCORPcoreStrategic or Co-development PartnerNCORP community site serving Illinois and Wisconsin with 40+ affiliate locations including Aurora BayCare Medical Center, Aurora Saint Luke's Medical Center, and Vince Lombardi Cancer Clinic sites.
• Baptist Memorial Health Care/Mid South NCORP ConsortiumcoreStrategic or Co-development PartnerNCORP consortium serving Arkansas, Mississippi, and Tennessee with Baptist Cancer Center and Mississippi Baptist Medical Center affiliates.
• Kaiser Permanente NCORPcoreStrategic or Co-development PartnerLarge integrated healthcare system network with 68+ affiliate locations across California, Colorado, Georgia, Hawaii, Oregon, and Washington. Led by Jennifer M. Suga, MD with headquarters in Oakland, California.
• Southeast Clinical Oncology Research Consortium NCORPcoreStrategic or Co-development PartnerMulti-state consortium serving Florida, Georgia, New York, North Carolina, South Carolina, Tennessee, and Virginia with 70+ affiliate locations including Novant Health, Cone Health Cancer Center, and Bon Secours Cancer Institute.
• International Society for Quality of Life Research (ISOQOL)strategicStrategic or Co-development PartnerCollaboration with ISOQOL for webinar series on Best Practices for Integrating Patient Reported Outcomes in Oncology Clinical Trials, including 6 educational sessions.
• Wisconsin NCORPcoreStrategic or Co-development PartnerServes Wisconsin communities through Marshfield Clinic system, ThedaCare cancer centers, and Gundersen Health System with 23+ affiliate locations.
• Hawaii NCORPcoreStrategic or Co-development PartnerServes Hawaii and Guam with 25+ affiliate locations including Queen's Medical Center, Kuakini Medical Center, Kapiolani Medical Center, Tripler Army Medical Center, and University of Hawaii Cancer Center.
• Puerto Rico NCORPcoreStrategic or Co-development PartnerServes Puerto Rico with 17+ affiliate locations including Centro Comprensivo de Cancer de UPR, HIMA San Pablo Oncologic Hospital, and San Juan City Hospital.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• SWOG Cancer Research Network: NCI-funded cancer clinical trials network conducting phase 2 and 3 trials across hundreds of sites. Comparable to NCORP as a multi-site cancer research network with both community-based and academic site participation.
• NRG Oncology: NCI-funded clinical trials research group focused on multi-modality cancer treatment and imaging research. NRG operates as a Research Base within the NCI clinical trials framework, directly comparable to NCORP's Research Base functions.
• ECOG-ACRIN Cancer Research Group: NCI-funded clinical trials research group that conducts cancer treatment and imaging trials. NCORP collaborated with ECOG-ACRN on the large-scale TMIST breast cancer screening trial, making it the most directly comparable cancer research network peer.
• Alliance for Clinical Trials in Oncology: NCI-funded cancer research network conducting clinical trials across diverse institutions. Functions as a Research Base in the NCI clinical trials infrastructure, providing direct comparability to NCORP's research operations.
• Children's Oncology Group: NCI-funded clinical trials group focused on pediatric and adolescent cancer research. Comparable to NCORP as a federally funded cancer research network coordinating multi-site clinical trials across the United States.

Others

• American Cancer Society: Major nonprofit funding cancer research and supporting clinical trial participation initiatives. While not a federal program, ACS funds cancer research and patient navigation programs that parallel NCORP's mission of expanding community access to cancer trials.
• National Institute on Aging (NIA): NIH institute addressing aging-related diseases including cancer in older adults. While not focused primarily on cancer, NIA conducts related clinical research in elderly populations that intersects with NCORP's community-based cancer research mission.

Broad incumbents

• NIH Clinical Center: The clinical research hospital of the National Institutes of Health on the Bethesda campus. While NCORP focuses on community settings, NIH Clinical Center is the federal government's primary intramural clinical research facility, sharing NIH parentage and federal research mission.
• National Clinical Trials Network (NCTN): NCI's broader clinical trials network that includes the adult cancer research groups (ECOG-ACRIN, SWOG, NRG, Alliance). NCORP complements NCTN by extending NCI-sponsored research into community-based settings that the NCTN cannot reach.
• National Cancer Institute (NCI): Parent organization of NCORP and the broader NCI clinical trials infrastructure. NCI is the federal government agency overseeing all federally funded cancer research, with NCORP operating as one of its flagship community-based programs.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/ncicaredelivres
• Facebookfacebook.com/cancer.gov
• LinkedInlinkedin.com/company/nationalcancerinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NCI Cancer Hospital